Clinical Trials Browser

Phase 2/3 × Sunitinib × Gastrointestinal × Clear all

NCT01164202 2022-03-18

SATURNE

Phase 2/3 Completed

78 enrolled 9 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03909724 2020-11-13

SUNRISE-CRC

Phase 2/3 Unknown

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms